Evidence map›Paper›PMID 32376886›Full record

ArticleScientific reports2020

Depletion of Csk preferentially reduces the protein level of LynA in a Cbl-dependent manner in cancer cells.

Takahisa Kuga, Yuka Yamane, Soujirou Hayashi, Masanari Taniguchi, Naoto Yamaguchi, Nobuyuki Yamagishi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Regulation, targets and functions of CSK.Frontiers in cell and developmental biology · 2023
    Review
  2. CSK-mediated signalling by integrins in cancer.Frontiers in cell and developmental biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Takahisa KugaLaboratory of Analytics for Biomolecules, Faculty of Pharmaceutical Science, Setsunan University, Osaka, 573-0101, Japan. takahisa.kuga@pharm.setsunan.ac.jp.
Yuka YamaneLaboratory of Analytics for Biomolecules, Faculty of Pharmaceutical Science, Setsunan University, Osaka, 573-0101, Japan.
Soujirou HayashiLaboratory of Analytics for Biomolecules, Faculty of Pharmaceutical Science, Setsunan University, Osaka, 573-0101, Japan.
Masanari TaniguchiLaboratory of Analytics for Biomolecules, Faculty of Pharmaceutical Science, Setsunan University, Osaka, 573-0101, Japan.
Naoto YamaguchiDepartment of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-8675, Japan.
Nobuyuki YamagishiLaboratory of Analytics for Biomolecules, Faculty of Pharmaceutical Science, Setsunan University, Osaka, 573-0101, Japan.
Setsunan University · JPChiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are eight human Src-family tyrosine kinases (SFKs). SFK members c-Src, c-Yes, Fyn, and Lyn are expressed in various cancer cells. SFK kinase activity is negatively regulated by Csk tyrosine kinase. Reduced activity of Csk causes aberrant activation of SFKs, which can be degraded by a compensatory mechanism depending on Cbl-family ubiquitin ligases. We herein investigated whether all SFK members are similarly downregulated by Cbl-family ubiquitin ligases in cancer cells lacking Csk activity. We performed Western blotting of multiple cancer cells knocked down for Csk and found that the protein levels of the 56 kDa isoform of Lyn (LynA), 53 kDa isoform of Lyn (LynB), c-Src, and Fyn, but not of c-Yes, were reduced by Csk depletion. Induction of c-Cbl protein levels was also observed in Csk-depleted cells. The reduction of LynA accompanying the depletion of Csk was significantly reversed by the knockdown for Cbls, whereas such significant recovery of LynB, c-Src, and Fyn was not observed. These results suggested that LynA is selectively downregulated by Cbls in cancer cells lacking Csk activity.

Indexed as

Gene Knockdown TechniquesCSK Tyrosine-Protein KinaseHCT116 CellsHeLa CellsHumansProto-Oncogene Proteins c-cblsrc-Family KinasesCSK protein, humanCSK Tyrosine-Protein Kinaselyn protein-tyrosine kinaseProto-Oncogene Proteins c-cblsrc-Family Kinases

Identifiers

PMID32376886
PMCPMC7203244
OpenAlexW3022472521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.